Heron Therapeutics | HRTX - Trade Debtors


Heron Therapeutics reported $89.59M in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
ALKERMES USD 334.02M 21.08M Dec/2025
Alnylam Pharmaceuticals USD 777.57M 187.2M Dec/2025
Amarin USD 126.83M 477K Dec/2025
ANI Pharmaceuticals USD 281.08M 28.46M Dec/2025
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 218.87M 212.05M Dec/2025
Eisai JPY 249.06B 25B Dec/2025
Emergent BioSolutions USD 290.1M 134.2M Jun/2023
Esperion Therapeutics USD 140.19M 21.21M Dec/2025
GlaxoSmithKline GBP 7.76B 545M Dec/2025
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Insmed USD 140.86M 75.6M Dec/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
Merck USD 12.12B 596M Sep/2025
Nektar Therapeutics USD 1.78M 1.12M Dec/2025
Neurocrine Biosciences USD 686.8M 41.2M Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 124.07M 8.8M Dec/2025
Regeneron Pharmaceuticals USD 5.74B 54M Dec/2025
Roche Holding CHF 11.9B 460M Dec/2025
Sangamo BioSciences USD 581K 110K Jun/2024
Surmodics USD 23.56M 288K Jun/2025
Ultragenyx Pharmaceutical USD 112.54M 11.92M Sep/2025
Veracyte USD 44.66M 3.17M Dec/2025
Vertex Pharmaceuticals USD 2.05B 106.4M Dec/2025